Previous 10 | Next 10 |
home / stock / szls:cc / szls:cc news
TORONTO, ON / ACCESSWIRE / November 15, 2023 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS), an integrated healthcare company with the first and only mRNA multi-cancer diagnostic for screening for multiple, key cancers from a single sample of blood - Aristotle, and an oncolo...
Aristotle and AVRT to be offered to My One Medical Source's Customer Base TORONTO, ON / ACCESSWIRE / November 14, 2023 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) (" StageZero " or the " Company "), an integrated healthcare company with the first and only mRNA multi-cancer diag...
Fission Uranium Corp. (FCU:CA) is expected to report for Q1 2024 Power Corporation of Canada Subordinate Voting Shares (POW:CA) is expected to report $1 for Q3 2023 Spark Power Group Inc. (SPG:CA) is expected to report for Q1 2024 ECN Capital Corp. (ECN:CA) is expected to report $0.02...
StageZero Life Sciences Ltd. (SZLS:CA) is expected to report for Q1 2024
Care Oncology Partners with WellnessScript to Offer Mental Health support to cancer patients TORONTO, ON / ACCESSWIRE / November 7, 2023 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) (" StageZero " or the " Company "), a vertically integrated healthcare company devoted to improving ...
CareOncology partners with The Source Functional Nutrition to offer nutritional guidance to cancer patients. TORONTO, ON / ACCESSWIRE / October 20, 2023 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) (" StageZero " or the " Company "), a vertically integrated healthcare company devo...
Toronto, Ontario--(Newsfile Corp. - June 20, 2023) - StageZero Life Sciences, Ltd. (TSX: SZLS) (OTCQB: SZLSF) (" StageZero " or the " Company "), a vertically integrated healthcare company devoted to improving the early detection and management of cancer and other chronic diseases through leadi...
Toronto, Ontario--(Newsfile Corp. - June 7, 2023) - StageZero Life Sciences, Ltd (TSX: SZLS) (OTCQB: SZLSF) ("StageZero" or the "Company") is pleased to report that shareholders voted in favour of all of the tabled resolutions listed in the Company's management information circular dated April 28...
Toronto, Ontario--(Newsfile Corp. - June 5, 2023) - StageZero Life Sciences, Ltd. (TSX: SZLS) ("StageZero" or the "Company") today announced that it will host a conference call as part of its Special and Annual General Meeting of Shareholders on Wednesday June 7, 2023, so that all shareholders ma...
Toronto, Ontario--(Newsfile Corp. - May 16, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company"), a vertically-integrated healthcare company devoted to improving the early detection and management of cancer and other chronic diseases through leading-edge molecular diagnostic...
News, Short Squeeze, Breakout and More Instantly...
Stagezero Life Sciences Ltd. Company Name:
SZLS:CC Stock Symbol:
TSXC Market:
Stagezero Life Sciences Ltd. Website:
TORONTO, ON / ACCESSWIRE / July 9, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTC PINK:SZLSF) (" StageZero " or the " Company "), an integrated healthcare company with the first and only mRNA gene expression multi-cancer diagnostic for screening for multiple, key cancers from a single sam...
TORONTO, ON / ACCESSWIRE / July 3, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTC PINK:SZLSF) (" StageZero " or the " Company "), an integrated healthcare company with the first and only mRNA gene expression multi-cancer diagnostic for screening for multiple, key cancers from a single sam...
TORONTO, ON / ACCESSWIRE / May 23, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) (" StageZero " or the " Company "), an integrated healthcare company with the first and only mRNA multi-cancer diagnostic for screening for multiple, key cancers from a single sample of blood - Aris...